Dynamic chromatin environment of key lytic cycle regulatory regions of the epstein-barr virus genome

Journal of Virology

Volumn 86, Issue 3, 2012, Pages 1809-1819

  Ramasubramanyan, Sharada ^a   Osborn, Kay ^a   Flower, Kirsty ^a   Sinclair, Alison J ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H2AX; HISTONE H3; HISTONE H4; LYSINE; LYSINE 27; LYSINE 9; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRAL TRANSCRIPTION FACTOR ZTA;

ARTICLE; BALF5 GENE; BMRF1 GENE; BRLF1 GENE; BZLF1 GENE; CHROMATIN; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; EPSTEIN BARR VIRUS; GENE FUNCTION; GENE INTERACTION; GENE SILENCING; HETEROCHROMATIN; HUMAN; HUMAN CELL; LIFE CYCLE; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY SEQUENCE; TRANSCRIPTION REGULATION; VIRAL GENETICS; VIRUS GENE; VIRUS GENOME; VIRUS LATENCY; VIRUS LYTIC REPLICATION; VIRUS REPLICATION;

BASE SEQUENCE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DNA PRIMERS; GENE SILENCING; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; METHYLATION; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 4;

EID: 84857078927     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06334-11     Document Type: Article

References (53)

1. Bark-Jones SJ, Webb HM, West MJ. 2006. EBV EBNA 2 stimulates CDK9-dependent transcription and RNA polymerase II phosphorylation on serine 5. Oncogene 25:1775-1785.
2. Bergbauer M, et al. 2010. CpG-methylation regulates a class of Epstein-Barr virus promoters. PLoS Pathog. 6:e1001114.
3. Bhende PM, Seaman WT, Delecluse HJ, Kenney SC. 2005. BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. J. Virol. 79:7338-7348.
4. Bhende PM, Seaman WT, Delecluse HJ, Kenney SC. 2004. The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nat. Genet. 36:1099-1104.
5. Bryant H, Farrell PJ. 2002. Signal transduction and transcription factor modification during reactivation of Epstein-Barr virus from latency. J. Virol. 76:10290-10298.
6. Chang LK, Liu ST. 2000. Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation. Nucleic Acids Res. 28: 3918-3925.
7. Countryman JK, Gradoville L, Miller G. 2008. Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virusinfected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors. J. Virol. 82:4706-4719.
8. Daigle D, et al. 2011. Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-Barr virus lytic cycle. J. Virol. 85:5628-5643.
9. Dickerson SJ, et al. 2009. Methylation-dependent binding of the Epstein-Barr virus BZLF1 protein to viral promoters. PLoS Pathog. 5:e1000356.
10. El-Guindy A, Heston L, Miller G. 2010. A subset of replication proteins enhances origin recognition and lytic replication by the Epstein-Barr virus ZEBRA protein. PLoS Pathog. 6:e1001054.
11. Ellis AL, Wang Z, Yu X, Mertz JE. 2010. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner. J. Virol. 84:6139-6152.
12. Ewald B, Sampath D, Plunkett W. 2007. H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation. Mol. Cancer Ther. 6:1239-1248.
13. Feederle R, et al. 2000. The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J. 19: 3080-3089.
14. Fernandez AF, et al. 2009. The dynamic DNA methylomes of doublestranded DNA viruses associated with human cancer. Genome Res. 19: 438-451.
15. Fixman ED, Hayward GS, Hayward SD. 1995. Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. J. Virol. 69: 2998-3006.
16. Fixman ED, Hayward GS, Hayward SD. 1992. trans-acting requirements for replication of Epstein-Barr virus ori-Lyt. J. Virol. 66:5030-5039.
17. Flemington E, Speck SH. 1990. Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64:1227-1232.
18. Flemington EK, Goldfeld AE, Speck SH. 1991. Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis. J. Virol. 65:7073-7077.
19. Flower K, et al. 2011. Epigenetic control of viral life-cycle by a DNAmethylation dependent transcription factor. PLoS One 6:e25922.
20. Gallagher A, et al. 1999. Detection of Epstein-Barr virus (EBV) genomes in the serum of patients with EBV-associated Hodgkin's disease. Int. J. Cancer 84:442-448.
21. Geisberg JV, Struhl K. 2004. Quantitative sequential chromatin immunoprecipitation, a method for analyzing co-occupancy of proteins at genomic regions in vivo. Nucleic Acids Res. 32:e151.
22. Gruffat H, Manet E, Sergeant A. 2002. MEF2-mediated recruitment of class II HDAC at the EBV immediate-early gene BZLF1 links latency and chromatin remodeling. EMBO Rep. 3:141-146.
23. Hui KF, Chiang AK. 2010. Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death. Int. J. Cancer 126:2479-2489.
24. Jenkins PJ, Binne UK, Farrell PJ. 2000. Histone acetylation and reactivation of Epstein-Barr virus from latency. J. Virol. 74:710-720.
25. Kalla M, Schmeinck A, Bergbauer M, Pich D, Hammerschmidt W. 2010. AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome. Proc. Natl. Acad. Sci. U. S. A. 107:850-855.
26. Karlsson QH, Schelcher C, Verrall E, Petosa C, Sinclair AJ. 2008. Methylated DNA recognition during the reversal of epigenetic silencing is regulated by cysteine and serine residues in the Epstein-Barr virus lytic switch protein. PLoS Pathog. 4:e1000005.
27. Kenney SC. 2007. Reactivation and lytic replication of EBV, p 403-433. In Arvin A, et al (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
28. Kraus RJ, Perrigoue JG, Mertz JE. 2003. ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus. J. Virol. 77: 199-207.
29. Kudoh A, et al. 2005. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J. Biol. Chem. 280:8156-8163.
30. Lukas J, Bohr VA, Halazonetis TD. 2006. Cellular responses to DNA damage: current state of the field and review of the 52nd Benzon Symposium. DNA Repair 5:591-601.
31. Miller G. 1989. The switch between EBV latency and replication. Yale J. Biol. Med. 62:205-213.
32. Murata T, et al. 2011. Involvement of Jun dimerization protein 2 (JDP2) in the maintenance of Epstein-Barr virus latency. J. Biol. Chem. 286: 22007-22016.
33. Packham G, Brimmell M, Cook D, Sinclair AJ, Farrell PJ. 1993. Strain variation in Epstein-Barr virus immediate-early genes. Virology 192: 541-550.
34. Palermo RD, Webb HM, West MJ. 2011. RNA polymerase II stalling promotes nucleosome occlusion and pTEFb recruitment to drive immortalization by Epstein-Barr virus. PLoS Pathog. 7:e1002334.
35. Paull TT, et al. 2000. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10:886-895.
36. Rickinson A, Kieff E (ed). 2007.Epstein-Barr virus, 5th ed.Lippincott/Williams and Wilkins, Philadelphia, PA.
37. Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM. 2000. Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J. Biol. Chem. 275:9390-9395.
38. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. 1998. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273:5858-5868.
39. Rowe M, Kelly GL, Bell AI, Rickinson AB. 2009. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology. Semin. Cancer Biol. 19:377-388.
40. Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132:365-386.
41. Sinclair AJ. 2003. bZIP proteins of human gammaherpesviruses. J. Gen. Virol. 84:1941-1949.
42. Sinclair AJ, Brimmell M, Shanahan F, Farrell PJ. 1991. Pathways of activation of the Epstein-Barr virus productive cycle. J. Virol. 65: 2237-2244.
43. Sinclair AJ, Farrell PJ. 1992. Epstein-Barr virus transcription factors. Cell Growth Differ. 3:557-563.
44. Soria C, Estermann FE, Espantman KC, O'Shea CC. 2010. Heterochromatin silencing of p53 target genes by a small viral protein. Nature 466: 1076-1081.
45. Speck SH, Chatila T, Flemington E. 1997. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol. 5:399-405.
46. Takada K. 1984. Cross-linking of surface immunoglobulins induces Epstein-Barr virus in Burkitt's lymphoma cell lines. Int. J. Cancer 33:27-32.
47. Takada K, Ono Y. 1989. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63:445-449.
48. Tarakanova VL, et al. 2007. Gammaherpesvirus kinase actively initiates a DNA damage response by inducing phosphorylation of H2AX to foster viral replication. Cell Host Microbe 1:275-286.
49. Tempera I, Wiedmer A, Dheekollu J, Lieberman PM. 2010. CTCF prevents the epigenetic drift of EBV latency promoter Qp. PLoS Pathog. 6.
50. Xie A, Scully R. 2007. Hijacking the DNA damage response to enhance viral replication: gammaherpesvirus 68 orf36 phosphorylates histone H2AX. Mol. Cell 27:178-179.
51. Ye J, Gradoville L, Daigle D, Miller G. 2007. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. J. Virol. 81:9279-9291.
52. Yin Q, Jupiter K, Flemington EK. 2004. The Epstein-Barr virus transactivator Zta binds to its own promoter and is required for full promoter activity during anti-Ig and TGF-β1 mediated reactivation. Virology 327: 134-143.
53. Young LS, et al. 1991. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J. Virol. 65:2868-2874.